November 17, 2025

‘Patent Dance’ Delays Biosimilars Despite FDA Shift

The FDA moves to speed biosimilar approvals, but rising patent barriers may still delay lower-cost alternatives.

Conexiant

November 17, 2025

Active PsA Linked to Maternal Hypertension in Pregnancy

Researchers explore links between psoriatic arthritis and maternal health.

Conexiant

November 05, 2025

Shame in Medicine—A Quiet Epidemic

A new movement in medicine aims to teach “shame competence,” helping physicians recognize and manage one of the field’s most corrosive yet overlooked emotions.

KFF Health News

October 31, 2025

Single-Injection Omvoh Option Simplifies Ulcerative Colitis Care

The FDA approved Eli Lilly’s interleukin-23p19 antagonist Omvoh (mirikizumab-mrkz) as a once-monthly single-injection maintenance option for adults with moderately to severely active ulcerative colitis.

Conexiant

October 29, 2025

FDA Pushes Faster, Cheaper Route for Biosimilar Approval

The FDA released new draft guidance to streamline biosimilar development.

Conexiant

October 29, 2025

H-1B Visa Changes: Who Pays the Price?

New fee structure could hit hardest where physicians are needed most.

Conexiant

October 24, 2025

A New Approach to Lowering Cardiovascular Risk?

Researchers evaluated obicetrapib’s effects on lipid levels and cardiovascular outcomes.

Conexiant

November 26, 2024

PsA Clusters Identified for Tailored Treatment: Longitudinal Study

A recent study reveals significant treatment response improvements in severe psoriatic arthritis and extensive psoriasis, emphasizing the need for personalized treatment strategies and sensitive outcome measures. (Source: Psoriatic Arthritis Research Consortium)

Conexiant

June 12, 2024

FAc Implant Shows Sustained Improvement in Uveitis

Long-term study highlights effectiveness of fluocinolone acetonide implant in managing non-infectious posterior uveitis, maintaining stable intraocular pressure.

Conexiant